Study using RNAi reveals previously unknown mice genes linked to cancer development

January 17, 2014 by Bob Yirka, Medical Xpress report
Aggressive head and neck squamous cell carcinoma; only cells at the proliferative edges are stem cells. Credit: Daniel Schramek

(Medical Xpress)—A combined team of researchers from Howard Hughes Medical Institute and the Icahn School of Medicine has discovered a previously unknown link between absent genes and the growth of tumors. In their paper published in the journal Science, the team describes a study they conducted using RNAi and how it led to the discovery of a previously unknown genetic link to cancerous tumors.

Over the past several years, scientists have learned that genes play a far greater role in cancer development than had been previously thought. One of the things they've discovered is that in addition to genetic markers that show a predisposition to certain types of cancers, there can also be a predisposition to cancer if certain genes are absent or don't work properly, i.e. those that cause the creation of proteins or other chemicals that fight or discourage the formation of tumors. In this new study, the research team was using a relatively new technique to suppress genes—in vivo RNA interference (RNAi), a method that allows for modifying genes in an embryo that doesn't itself cause damage or changes to the embryo—to isolate genes that have been identified with tumor growth () in the head and necks of mice.

Prior to the development of in vivo RNAi, researchers would modify genetic components and then graft them onto an embryo. Though effective in some respects it also suffers from causing possible genetic changes due to immune response and also embryonic response to the wound that was created. The new method is non-invasive and allows for much more accurate placement of changed genetic material.

The researchers were using the technique to shut off different genes to learn more about what happens to mice that grow to maturity when they don't have them, i.e. which develop tumors and which don't. In so doing, the team confirmed several previously associated with development—the kind that are responsible for causing the production of proteins that fight tumors. Surprisingly, however, they also discovered seven that had never been identified before.

This discovery adds more information about cancer causing agents in mice, of course, which might be applicable to humans, but it also proves the worth of RNAi, and indicates that it might just become a major research tool in the fight against cancer in general.

Explore further: Awakening genes that suppress tumors

More information: Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas, Science 17 January 2014: Vol. 343 no. 6168 pp. 309-313 DOI: 10.1126/science.1248627

Mining modern genomics for cancer therapies is predicated on weeding out "bystander" alterations (nonconsequential mutations) and identifying "driver" mutations responsible for tumorigenesis and/or metastasis. We used a direct in vivo RNA interference (RNAi) strategy to screen for genes that upon repression predispose mice to squamous cell carcinomas (SCCs). Seven of our top hits—including Myh9, which encodes nonmuscle myosin IIa—have not been linked to tumor development, yet tissue-specific Myh9 RNAi and Myh9 knockout trigger invasive SCC formation on tumor-susceptible backgrounds. In human and mouse keratinocytes, myosin IIa's function is manifested not only in conventional actin-related processes but also in regulating posttranscriptional p53 stabilization. Myosin IIa is diminished in human SCCs with poor survival, which suggests that in vivo RNAi technology might be useful for identifying potent but low-penetrance tumor suppressors.

Related Stories

Awakening genes that suppress tumors

October 10, 2013
(Medical Xpress)—When genes that normally suppress tumor growth are themselves suppressed, cancer cells can grow and proliferate uncontrollably. A new study led by a researcher at Yale University has uncovered the pathway ...

Genetic switch shuts down lung cancer tumors in mice

October 25, 2012
Yale researchers manipulated a tiny genetic switch and halted growth of aggressive lung cancer tumors in mice and even prevented tumors from forming.

Study allows better prediction of the risk of hereditary cancer

January 15, 2014
An international study has developed a refined method to identify people at risk for certain inherited cancer as a result of Lynch syndrome.

New technique in RNA interference cuts time and cost in genetic screens

August 15, 2013
(Medical Xpress)—There is a new contender in the field of gene discovery, and it's giving knockout mice a run for their money. Researchers at The Rockefeller University have shown that a new technique using RNA interference ...

Genetic screening identifies genes driving resistance with a guide RNA library

December 23, 2013
Researchers have developed a method to create a comprehensive library of mutations across all genes in the mouse genome. This library can be used to examine the role of every gene in different cell types.

Researchers discover possible trigger for spread of head and neck cancer cells

May 8, 2013
(Medical Xpress)—Very little has been known about the epigenetic events—developmental and environmental factors affecting genes—that occur prior to the invasive growth of head and neck squamous cell carcinomas and their ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.